Skip to content

Symphony IL-6 Reference Range Study

Symphony IL-6 Reference Range Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05048888
Enrollment
120
Registered
2021-09-17
Start date
2021-08-31
Completion date
2024-03-30
Last updated
2023-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Brief summary

Symphony IL-6 is a device that quantitates human IL-6 by fluorescence enzyme immunoassay (FEIA) from whole-blood specimens. Use of Symphony IL- 6 removes the need for plasma separation before testing. Symphony IL-6 comprises two components, the Symphony Fluorescence Immunoanalyzer and the Symphony IL-6 Cartridge. Whole blood is added to the cartridge and then up to six cartridges can be inserted into the immunoanalyzer. After 20 minutes a readout and printout are given with a quantitative IL-6 concentration. The used cartridges are fully enclosed and can be easily disposed of in general hospital bio-waste. Given the nature of this device and its portability, there is potential for future deployment as a point-of-care (POC) device. The objective of this study is to establish a reference range for Symphony IL-6 in a cohort of apparently healthy individuals.

Interventions

None listed

Sponsors

Bluejay Diagnostics, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* Subject is willing and able to provide informed consent * \> 18 years of age * Whole blood specimen collected in EDTA anticoagulant tubes * Minimum volume of 100µL for Symphony IL-6 testing * Specimen is available for testing within 12 hours from collection * C-Reactive Protein (CRP) \< 10 mg/L

Exclusion criteria

* Subjects presenting with a fever * Subjects with a diagnosis of COVID-19 or other respiratory illness at the time of collection * Subjects otherwise self-reported as unhealthy * Hemolyzed specimens

Design outcomes

Primary

MeasureTime frameDescription
IL-6 Reference Range StudySpecimen is tested within 12 hours from collectionEstablishment of the interleukin-6 concentration in whole blood samples from healthy individuals.

Countries

United States

Contacts

Primary ContactJason Cook, PhD
jason.cook@bluejaydx.com844-327-7078

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026